These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 24055326)

  • 21. Evidence-based medicine-When observational studies are better than randomized controlled trials.
    Bosdriesz JR; Stel VS; van Diepen M; Meuleman Y; Dekker FW; Zoccali C; Jager KJ
    Nephrology (Carlton); 2020 Oct; 25(10):737-743. PubMed ID: 32542836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing observational studies for credible causal inference in addiction research-Directed acyclic graphs, modified disjunctive cause criterion and target trial emulation.
    Chan GCK; Sun T; Stjepanović D; Vu G; Hall WD; Connor JP; Leung J
    Addiction; 2024 Jun; 119(6):1125-1134. PubMed ID: 38343103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities.
    Jongen PJ
    Mult Scler Relat Disord; 2019 Oct; 35():142-149. PubMed ID: 31394404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness research in cancer with observational data.
    Giordano SH
    Am Soc Clin Oncol Educ Book; 2015; ():e330-5. PubMed ID: 25993193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.
    Hernán MA; Robins JM
    Am J Epidemiol; 2016 Apr; 183(8):758-64. PubMed ID: 26994063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inferring causality from observational studies: the role of instrumental variable analysis.
    Fu R; Kim SJ
    Kidney Int; 2021 Jun; 99(6):1303-1308. PubMed ID: 33811980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core concepts in pharmacoepidemiology: Measurement of medication exposure in routinely collected healthcare data for causal inference studies in pharmacoepidemiology.
    Thai TN; Winterstein AG
    Pharmacoepidemiol Drug Saf; 2024 Mar; 33(3):e5683. PubMed ID: 37752827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between treatment effects in a randomised controlled trial and an observational study using propensity scores in primary care.
    Stuart BL; Grebel LE; Butler CC; Hood K; Verheij TJM; Little P
    Br J Gen Pract; 2017 Sep; 67(662):e643-e649. PubMed ID: 28760739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of Assessing Therapeutic or Diagnostic Outcomes with Observational Data.
    Weintraub WS; Yeh RW
    Am J Med; 2018 Feb; 131(2):206-210. PubMed ID: 29103925
    [No Abstract]   [Full Text] [Related]  

  • 32. Central concepts for randomized controlled trials and other emerging trial designs.
    Heindel P; Dieffenbach BV; Freeman NLB; McGinigle KL; Menard MT
    Semin Vasc Surg; 2022 Dec; 35(4):424-430. PubMed ID: 36414358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squeezing observational data for better causal inference: Methods and examples for prevention research.
    Garcia-Huidobro D; Michael Oakes J
    Int J Psychol; 2017 Apr; 52(2):96-105. PubMed ID: 27094382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.
    Hernán MA
    Am J Epidemiol; 2015 Nov; 182(10):834-9. PubMed ID: 26507306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active-comparator design and new-user design in observational studies.
    Yoshida K; Solomon DH; Kim SC
    Nat Rev Rheumatol; 2015 Jul; 11(7):437-41. PubMed ID: 25800216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness clinical trials to advance treatment of myasthenia gravis.
    Guptill JT; Raja S; Sanders DB; Narayanaswami P
    Ann N Y Acad Sci; 2018 Feb; 1413(1):69-75. PubMed ID: 29377158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncovering interpretable potential confounders in electronic medical records.
    Zeng J; Gensheimer MF; Rubin DL; Athey S; Shachter RD
    Nat Commun; 2022 Feb; 13(1):1014. PubMed ID: 35197467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.
    Targownik LE; Suissa S
    Am J Gastroenterol; 2015 Dec; 110(12):1647-50. PubMed ID: 26323186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causal inference from experiment and observation.
    Zwahlen M; Salanti G
    Evid Based Ment Health; 2018 Feb; 21(1):34-38. PubMed ID: 29289944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Matching in observational research: from the directed acyclic graph perspective].
    Luo T; Wang L; Tian T; Fu WH; Pei HL; Zheng YJ; Dai JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Apr; 42(4):740-744. PubMed ID: 34814461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.